Cited by 119Cancer Cells and MetastasisCancer-related Molecular PathwaysHematopoietic Stem Cell Transplantation

Cell cycle inhibitors in normal and tumor stem cells.

Cheng, Tao·2004·Oncogene

Abstract

Emerging data suggest that stem cells may be one of the key elements in normal tissue regeneration and cancer development, although they are not necessarily the same entity in both scenarios. As extensively demonstrated in the hematopoietic system, stem cell repopulation is hierarchically organized and is intrinsically limited by the intracellular cell cycle inhibitors. Their inhibitory effects appear to be highly associated with the differentiation stage in stem/progenitor pools. While this negative regulation is important for maintaining homeostasis, especially at the stem cell level under physiological cues or pathological insults, it constrains the therapeutic use of adult stem cells in vitro and restricts endogenous tissue repair after injury. On the other hand, disruption of cell cycle inhibition may contribute to the formation of the so-called 'tumor stem cells' (TSCs) that are currently hypothesized to be partially responsible for tumorigenesis and recurrence of cancer after conventional therapies. Therefore, understanding how cell cycle inhibitors control stem cells may offer new strategies not only for therapeutic manipulations of normal stem cells but also for novel therapies selectively targeting TSCs.

Integrity signals

Registry

Crossref · 10.1038/sj.onc.1207945

Cites

132 of 132 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Cheng, T.
Affiliations
University of Pittsburgh (US)
Corresponding author
Cheng, Tao
Venue
Oncogene
Published
2004-09-20
Volume
23
Issue
43
Pages
7256-7266
ISSN
  • 0950-9232 (ISSN-L)
  • 1476-5594
OpenAlex
W1991227964
Cited by
117
References
128
Citations by year
2026: 1 · 2025: 3 · 2024: 3 · 2023: 14 · 2022: 1 · 2021: 2 · 2020: 3 · 2019: 2 · 2018: 4 · 2017: 4 · 2016: 8 · 2015: 4 · 2014: 5 · 2013: 8 · 2012: 4
FWCI
0.83
Type
journal article
Language
en
Open access
closed
Locations
  • Oncogene (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • American Society of Hematology
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (HL70561, R01HL070561)
  • National Institute of Diabetes and Digestive and Kidney Diseases (K08DK002761, DK 02761)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
Keywords
cell cycle inhibitors, stem cells, cancer stem cells, hematopoietic stem cells, stem cell differentiation, tissue regeneration, tumor recurrence, carcinogenesis, adult stem cell therapy, tissue homeostasis
MeSH terms
Animals, Cell Cycle, Cell Division, Humans, Neoplasm Proteins, Saccharomyces cerevisiae, Stem Cells, Neoplastic Stem Cells, Cyclins, Mice, Knockout, Cell Cycle Proteins, Cyclin-Dependent Kinases, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review